Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22525 | 322 | 31.3 | 47% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 132 | 22818 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SMALL ANGLE AND WIDE ANGLE X RAY SCATTERING | Author keyword | 2 | 67% | 1% | 2 |
| 2 | ARETAIEO UNIV HOSP | Address | 1 | 100% | 1% | 2 |
| 3 | MMK3 | Author keyword | 1 | 100% | 1% | 2 |
| 4 | BIOPHYS NANOSYST IBN | Address | 1 | 30% | 1% | 3 |
| 5 | LACTAM BRIDGE | Author keyword | 1 | 30% | 1% | 3 |
| 6 | CONFORMATION BY NMR | Author keyword | 1 | 40% | 1% | 2 |
| 7 | MM1 | Author keyword | 1 | 40% | 1% | 2 |
| 8 | PARTIAL INTERDIGITATION | Author keyword | 1 | 40% | 1% | 2 |
| 9 | AT1 ANTAGONISTS | Author keyword | 1 | 16% | 1% | 4 |
| 10 | AT1 AT2 RECEPTOR SUBTYPES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SMALL ANGLE AND WIDE ANGLE X RAY SCATTERING | 2 | 67% | 1% | 2 | Search SMALL+ANGLE+AND+WIDE+ANGLE+X+RAY+SCATTERING | Search SMALL+ANGLE+AND+WIDE+ANGLE+X+RAY+SCATTERING |
| 2 | MMK3 | 1 | 100% | 1% | 2 | Search MMK3 | Search MMK3 |
| 3 | LACTAM BRIDGE | 1 | 30% | 1% | 3 | Search LACTAM+BRIDGE | Search LACTAM+BRIDGE |
| 4 | CONFORMATION BY NMR | 1 | 40% | 1% | 2 | Search CONFORMATION+BY+NMR | Search CONFORMATION+BY+NMR |
| 5 | MM1 | 1 | 40% | 1% | 2 | Search MM1 | Search MM1 |
| 6 | PARTIAL INTERDIGITATION | 1 | 40% | 1% | 2 | Search PARTIAL+INTERDIGITATION | Search PARTIAL+INTERDIGITATION |
| 7 | AT1 ANTAGONISTS | 1 | 16% | 1% | 4 | Search AT1+ANTAGONISTS | Search AT1+ANTAGONISTS |
| 8 | AT1 AT2 RECEPTOR SUBTYPES | 1 | 50% | 0% | 1 | Search AT1+AT2+RECEPTOR+SUBTYPES | Search AT1+AT2+RECEPTOR+SUBTYPES |
| 9 | BINDING POTENCY | 1 | 50% | 0% | 1 | Search BINDING+POTENCY | Search BINDING+POTENCY |
| 10 | HISTIDINE METHYLATION | 1 | 50% | 0% | 1 | Search HISTIDINE+METHYLATION | Search HISTIDINE+METHYLATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TERMINAL AROMATIC RESIDUE | 27 | 92% | 3% | 11 |
| 2 | SARMESIN | 11 | 78% | 2% | 7 |
| 3 | SER42 PHE LEU LEU ARG46 MOTIF SEQUENCE | 3 | 100% | 1% | 3 |
| 4 | ANTI PLASMODIUM ACTIVITY | 3 | 50% | 1% | 4 |
| 5 | AT1 ANTAGONIST | 3 | 60% | 1% | 3 |
| 6 | RING CLUSTER | 3 | 60% | 1% | 3 |
| 7 | AT1 ANTAGONIST LOSARTAN | 2 | 67% | 1% | 2 |
| 8 | RECEPTOR SIMULATING ENVIRONMENTS | 2 | 67% | 1% | 2 |
| 9 | MEMBRANE BILAYERS | 1 | 20% | 2% | 5 |
| 10 | II ANALOGS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Conformation and bioactivity. Design and discovery of novel antihypertensive drugs | 2004 | 21 | 50 | 44% |
| DESIGNING PEPTIDE MIMETICS | 1994 | 55 | 15 | 40% |
| AT1 antagonists: a patent review (2008-2012) | 2013 | 3 | 26 | 23% |
| Efforts to understand the molecular basis of hypertension through drug : membrane interactions | 2004 | 20 | 58 | 24% |
| On the structural basis of the hypertensive properties of angiotensin II: A solved mystery or a controversial issue? | 2004 | 13 | 111 | 31% |
| Round and round we go: Cyclic peptides in disease | 2006 | 63 | 87 | 13% |
| STRUCTURE AND STRUCTURE-FUNCTION RELATIONS OF NATURALLY PEPTIDES | 1994 | 1 | 27 | 59% |
| COMPUTATIONAL MOLECULAR MODELING IN PEPTIDE DRUG DESIGN | 1994 | 37 | 116 | 13% |
| APPROACH TO SOLUTION OF THE PROBLEM OF THE STRUCTURAL AND FUNCTIONAL-ORGANIZATION OF NATURAL PEPTIDES | 1985 | 0 | 10 | 90% |
| BETA-ALANINE AND ITS DERIVATIVE | 1991 | 0 | 4 | 25% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ARETAIEO UNIV HOSP | 1 | 100% | 0.6% | 2 |
| 2 | BIOPHYS NANOSYST IBN | 1 | 30% | 0.9% | 3 |
| 3 | CANCERBIOBANK | 1 | 50% | 0.3% | 1 |
| 4 | CIENCIAS BIOMED II | 1 | 50% | 0.3% | 1 |
| 5 | FISIOL FARMACOL VASC | 1 | 50% | 0.3% | 1 |
| 6 | PHARMACOGNOSY PHARMACEUT TECHNOL | 1 | 50% | 0.3% | 1 |
| 7 | PRACTICE MED EDUC | 1 | 50% | 0.3% | 1 |
| 8 | INSIBIOCONICET | 0 | 25% | 0.3% | 1 |
| 9 | PHARMACOGNOSY SECT | 0 | 25% | 0.3% | 1 |
| 10 | DDDC | 0 | 20% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000185466 | CANDESARTAN CILEXETIL//ANGIOTENSIN II RECEPTOR ANTAGONIST//LOSARTAN |
| 2 | 0.0000161805 | AT2 RECEPTOR//COMPOUND 21//ANGIOTENSIN RECEPTORS |
| 3 | 0.0000091004 | BETA TURN MIMETICS//BICYCLIC DIPEPTIDE//PHTHALOYL PROTECTION |
| 4 | 0.0000073356 | BENZHYDRYLAMINE RESIN//TOAC//CHIRAL NITROXIDES |
| 5 | 0.0000073090 | PEPTIDE T//PEPTIDE T ANALOGS//D ALA1 PEPTIDE T AMIDE |
| 6 | 0.0000066366 | ENDOTHELAEMIA//INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR//ENDOTHELEMIA |
| 7 | 0.0000061203 | ANGIOTENSIN IV//AT4 RECEPTOR//AMINOPEPTIDASE A |
| 8 | 0.0000058407 | CHEM BIOL PEPTIDE//ENDOMORPHIN 2//ENDOMORPHIN |
| 9 | 0.0000056519 | ANOREXIGENIC PEPTIDE//CYANIDE ADDITION//5 RAPID AMPLIFICATION OF CDNA ENDS |
| 10 | 0.0000051446 | ORGAN CHEM BIOTECHNOL SECT//C ALPHA TETRASUBSTITUTED ALPHA AMINO ACIDS//BIOPOLYMER |